We are live on ! Find out more
RNVA

Rennova Health, Inc.
RNVA

Delisted

RNVA was delisted on the 24th of October, 2017.

8 hedge funds and large institutions have $236K invested in Rennova Health, Inc. in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more capital invested

Capital invested by funds: $161K → $236K (+$75K)

9.66% more ownership

Funds ownership: 1.59%11.25% (+9.7%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

11% less funds holding

Funds holding: 98 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change

RNVA Hedge Fund Activity: Q2 2017 in Review

8 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. (RNVA) for Q2 2017, worth a combined $236K — up 47% from $161K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of RNVA and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $272K. The largest seller was Morgan Stanley, exiting entirely with an estimated $86K sold.

  • 8 institutional investors held Rennova Health, Inc. (RNVA) as of Q2 2017, down from 9 in Q1 2017.
  • Funds reported $236K of Rennova Health, Inc. stock for Q2 2017, up 47% quarter-over-quarter.
  • 3 funds opened new Rennova Health, Inc. positions in Q2 2017 and 4 closed out, a net change of -1 holder.
  • The largest Rennova Health, Inc. buyer in Q2 2017 was Virtu KCG Holdings, an estimated $272K added.
  • The largest Rennova Health, Inc. seller in Q2 2017 was Morgan Stanley, an estimated $86K sold.

Based on aggregated 13F filings for Q2 2017.